Pharmacopsychiatry 2014; 47(01): 1-6
DOI: 10.1055/s-0033-1358683
Review
© Georg Thieme Verlag KG Stuttgart · New York

Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review. Part III: Mood Stabilizers and Anxiolytic Drugs

A. La Torre
2   Psichiatria, Ospedale di Rovereto, Rovereto, Italy
,
G. Giupponi
1   Psychiatrie, S Maurizio Hospital, Bolzano, Italy
,
D. M. Duffy
1   Psychiatrie, S Maurizio Hospital, Bolzano, Italy
,
M. Pompili
3   Department of Psychiatry, Sant’Andrea Hospital, “La Sapienza” University of Rome, Roma, Italy
,
M. Grözinger
4   Psychiatry, University Hospital Aachen, Aachen, Germany
,
H. P. Kapfhammer
5   Psychiatry, University Hospital Graz, Graz, Austria
,
A. Conca
1   Psychiatrie, S Maurizio Hospital, Bolzano, Italy
› Author Affiliations
Further Information

Publication History

received 08 August 2013
revised 25 September 2013

accepted 04 October 2013

Publication Date:
12 November 2013 (online)

Abstract

Introduction:

Sexual dysfunction is a potential side effect of mood stabilizers and anxiolytic drugs: this article presents a critical review of the current literature. Although many studies have been published on sexual side effects of psychopharmacological treatment, only a minority relate to mood stabilizers and anxiolytic drugs. Most of these studies are not methodologically robust, few are RCTs and most did not use a validated rating scale to evaluate sexual functioning. In addition, many of the studies on sexual dysfunction associated with mood stabilizers and anxiolytic drugs are limited by other methodological flaws. While there is evidence to suggest that mood stabilizers, with some exceptions, negatively affect sexual functioning, there is still insufficient evidence to draw any clear conclusions about the effects of anxiolytic drugs on sexual function. There is some weak evidence to indicate that switching from enzyme-inducing to non-enzyme-inducing anticonvulsant drugs, could be clinically useful. Some researchers recommend that sexual dysfunction in patients taking antiepileptic drugs should in general be treated according to standard guidelines for the management of sexual dysfunction, since reliable data on special populations is not available. However, specific approaches may be useful, but cannot yet be recommended until further validating research has been conducted. We did not find evidence supporting the use of any specific treatment strategy for sexual dysfunction associated with anxiolytic treatment.

Methods:

This study was conducted in 2013 using the paper and electronic resources of the library of the Azienda Provinciale per i Servizi Sanitari (APSS) in Trento, Italy (http://atoz.ebsco.com/Titles/2793). The library has access to a wide range of databases including DYNAMED, MEDLINE Full Text, CINAHL Plus Full Text, The Cochrane Library, Micromedex healthcare series, BMJ Clinical Evidence. The full list of available journals can be viewed at http://atoz.ebsco.com/Titles/2793, or at the APSS web site (http://www.apss.tn.it). In completing this review, a literature search was conducted using the key words “anxiolytic drugs”, “mood stabilizers”, “benzodiazepines”, “psychotrophic drugs”, “sexual dysfunction”, “sexual side effects”, “treatment-emergent sexual dysfunction”. All resulting listed articles were reviewed.

Discussion:

This review includes studies that investigated the relationship between mood stabilizer and anxiolytic drug treatment and sexual dysfunction. The purpose was to identify possible intervention strategies for sexual dysfunction related to these drugs.

 
  • References

  • 1 Boyarsky BK, Hirschfeld RM. The management of medication-induced sexual dysfunction. Essent Psychopharmacol 2000; 3: 39-58
  • 2 Gitlin M. Sexual dysfunction with psychotropic drugs. Expert Opin Pharmacother 2003; 4: 2259-2269
  • 3 Labbate LA. Psychotropics and sexual dysfunction: the evidence and treatments. Adv Psychosom Med 2008; 29: 107-130
  • 4 Soreca I, Fagiolini A. Psicofarmaci e disfunzioni sessuali: meccanismi, prevalenza e gestione clinica. Rivista Sperimentale di Freniatria 2006; 1: 103-122
  • 5 Serretti A, Chiesa A. Sexual side effects of pharmacological treatment of psychiatric diseases. Clin Pharmacol Ther 2011; 89: 142-147
  • 6 Stimmel GL, Gutierrez MA. Sexual dysfunction and psychotropic medications. CNS Spectr 2006; 11: 24-30
  • 7 La Torre A, Giupponi G, Duffy D et al. Sexual dysfunction related to psychotropic drugs: a critical review. Part I: antidepressants. Pharmacopsyciatry 2013; 46: 191-199
  • 8 Gastaut H, Collomb H. Etude du comportement sexuel chez les épileptiques psychomoteurs. Ann Méd psychol 1954; 112: 657-696
  • 9 Blumer D. Hypersexual episodes in temporal lobe epilepsy. Am J Psychiat 1970; 126: 1099-1106
  • 10 Blumer D, Walker AE. Sexual behaviour in temporal lobe epilepsy. Arch Neurol 1967; 16: 37-43
  • 11 Gauthier-Smith PC. Atteinte des fonctions cérébrales et troubles du comportement sexuel. Rev Neurol 1980; 136: 311-319
  • 12 Lossius MI, Taubøll E, Mowinckel P et al. Reversible effects of antiepileptic drugs on reproductive endocrine function in men and women with epilepsy. A prospective randomized double-blind withdrawal study. Epilepsia 2007; 48: 1875-1882
  • 13 Verrotti A, Basciani F, Morresi S et al. Serum sex hormone levels in young male patients with epilepsy receiving carbamazepine and valproic acid and after their withdrawal. Eur J Pediatr 2000; 159: 871-872
  • 14 Røste LS, Taubøll E, Møkrid L et al. Antiepileptic drugs alter reproductive endocrine hormones in men with epilepsy. Eur J Neurol 2005; 12: 118-124
  • 15 Calabrò RS, Marino S, Bramanti P. Sexual and reproductive dysfunction associated with antiepileptic drug use in men with epilepsy. Expert Rev. Neurotherapeutics 2011; 11: 887-895
  • 16 Harden CL. Sexuality in women with epilepsy. Epilepsy Behav 2005; 7: S2-S6
  • 17 Harden CL. Sexual dysfunction in women with epilepsy. Seizure 2008; 17: 131-135
  • 18 Lundberg PO, Ertekin C, Ghezzi A et al. Neurosexology. Guidelines for Neurologists. Eur J Neurol 2001; 8: 2-24 – Available on line at: http://www2.hu-berlin.de/sexology/BIB/Neurosexology.htm (accessed: 2 June, 2013)
  • 19 Bartlik BD, Rosenfeld S, Beaton C. Assessment of sexual functioning: Sexual history taking for health care practitioners. Epilepsy Behav 2005; 7: S15-S20
  • 20 Herman S. Sex hormones and epilepsy: no longer just for women. Epilepsy Currents 2008; 8: 6-8
  • 21 Herzog AG, Drislane F, Schomer DL et al. Differential effects of antiepileptic drugs on sexual function and reproductive hormones in men with epilepsy: interim analysis of a comparison between lamotrigine and enzyme-inducing antiepileptic drugs. Epilepsia 2004; 45: 764-768
  • 22 Herzog AG, Drislane FW, Schomer DL et al. Differential effects of antiepileptic drug on sexual function and hormones in men with epilepsy. Neurology 2005; 65: 1016-1020
  • 23 Herzog AG, Fowler KM. Sexual hormones and epilepsy: threat and opportunities. Curr Opin Neurol 2005; 18: 167-172
  • 24 Hellmis E. Sexual problems in males with epilepsy – an interdisciplinary challenge!. Seizure 2008; 17: 136-140
  • 25 Mattson RH, Cramer JA. Epilepsy, sex hormones and epileptic drugs. Epilepsia 1985; 26: S40-S51
  • 26 Mölleken D, Richter-Appelt H, Stodieck S et al. Sexual quality of life in epilepsy: Correlations with sex hormone blood levels. Epilepsy Behav 2009; 14: 226-231
  • 27 Montouris G, Morris GL. Reproductive and sexual dysfunction in men with epilepsy. Epilepsy Behav 2005; 7: S7-S14
  • 28 Morris GL, Vanderkolk C. Human sexuality, sex hormones, and epilepsy. Epilepsy Behav 2005; 7: S22-S28
  • 29 Murialdo G, Galimberti CA, Fonzi S et al. Sex hormones patients and pituitary function in male epileptic with altered or normal sexuality. Epilepsia 1995; 36: 360-365
  • 30 Isojärvi JIT, Jouko IT, Taubøll E et al. Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drugs 2005; 19: 207-223
  • 31 Isojärvi JI, Löfgren E, Juntunen KS et al. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology 2004; 62: 247-253
  • 32 Mikkonen K, Vainionpää LK, Pakarinen AJ et al. Long-term reproductive endocrine health in young women with epilepsy during puberty. Neurology 2004; 62: 445-450
  • 33 Penovich PE. The effects of epilepsy and its treatment on sexual and reproductive function. Epilepsia 2000; 41: S53-S61
  • 34 Rättyä J, Turkka J, Pakarinen AJ et al. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy. Neurology 2001; 56: 31-36
  • 35 Røste LS, Taubøll E, Haugen TB et al. Alterations in semen parameters in men with epilepsy treated with valproate or carbamazepine monotherapy. Eur J Neurol 2003; 10: 501-506
  • 36 Duncan S, Blacklaw J, Beastall GH et al. Sexual function in women with epilepsy. Epilepsia 1997; 38: 1074-1081
  • 37 Luef GJ. Epilepsy and sexuality. Seizure 2008; 17: 127-30
  • 38 Morrel MJ. Sexual dysfunction in epilepsy. Epilepsia 1991; 32: S38-S45
  • 39 Morrel MJ, Guldner GT. Self-reported sexual function and sexual arousability in women with epilepsy. Epilepsia 1996; 37: 1204-1210
  • 40 Morrell MJ, Flynn KL, Done S et al. Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs. Epilepsy Behav 2005; 6: 360-365
  • 41 Duncan S, Blacklaw J, Beastall GH et al. Antiepileptic drug therapy and sexual function in men with epilepsy. Epilepsia 1999; 40: 197-204
  • 42 Kuba R, Pohanka M, Zákopcan J et al. Sexual dysfunctions and blood hormonal profile in men with focal epilepsy. Epilepsia 2006; 47: 2135-2140
  • 43 Talbot JA, Sheldrick R, Caswell H et al. Sexual function in men with epilepsy: How important is testosterone?. Neurology 2008; 70: 1346-1352
  • 44 Gil-Nagel A, López-Muñoz F, Serratosa JM et al. Effect of lamotrigine on sexual function in patients with epilepsy. Seizure 2006; 15: 142-149
  • 45 Gutierrez MA, Mushtaq R, Stimmel G. Sexual dysfunction in women with epilepsy: role of antiepileptic drugs and psychotropic medications. Int Rev Neurobiol 2008; 83: 157-167
  • 46 La Torre A, D’Antonio P. Impotenze di natura neurologica. In Rifelli G, Rifelli G. (eds.). Impotenza maschile, femminile, di coppia. Roma: Scione; 2010: 353-379
  • 47 Schneck CD, Marshall RT, Gundersen D. Sexual side effects associated with valproate. J Clin Psychopharmacol 2002; 22: 532-534
  • 48 Luef G, Kramer G, Stefan H. Oxcarbazepine treatment in male epilepsy patients improves pre-existing sexual dysfunction. Acta Neurol Scand 2009; 119: 94-99
  • 49 Boora K, Chiappone K, Dubovsky SL. Oxcarbazepine-induced reversible anorgasmia and ejaculatory failure: a case report. Prim Care Companion J Clin Psychiatry 2009; 11: 173-174
  • 50 Calabrò RS, Ferlazzo E, Italiano D et al. Dose-dependent oxcarbazepine-related anorgasmia. Epilepsy Behav 2010; 17: 287-288
  • 51 Calabrò RS, Italiano D, Pollicino P et al. Oxcarbazepine-related retrograde ejaculation. Epilepsy Behav 2012; 25: 174-175
  • 52 Elia J, Imbrogno N, Delfino M et al. Retrograde ejaculation and abnormal hormonal profile in a subject under treatment with valproate and phenytoin. Archivio Italiano di Urologia, Andrologia 2010; 82: 193-194
  • 53 Elia J, Imbrogno N, Delfino M et al. Retrograde ejaculation and abnormal hormonal profile in a subject under treatment with valproate and phenytoin. Reaction Weakly 2011; 1344: 26-27
  • 54 Brannon GE, Rolland PD. Anorgasmia in a patient with bipolar disorder type 1 treted with gabapentin. J Clin Psychoparmacol 2000; 20: 379-381
  • 55 Drabkin R, Calhoun L. Anorgasmia and withdrawal syndrome in a woman taking gabapentin. Can J Psychiatry 2003; 48: 125-126
  • 56 Grant AC, Oh H. Gabapentin-induced anorgasmia in women. Am J Psychiatry 2002; 159: 1247
  • 57 Kaufman KR, Struck PJ. Gabapentin-induced sexual dysfunction. Epilepsy Behav 2011; 21: 324-326
  • 58 Labbate LA, Rubey RN. Gabapentin-induced ejaculatory failure and anorgasmia. Am J Psychiatry 1999; 156: 972
  • 59 Calabrò RS. Gabapentin and sexual dysfunction: an overlooked and underreported problem?. Epilepsy Behav 2011; 22: 818
  • 60 Husain AM, Carwile ST, Miller PP et al. Improved sexual function in three men taking lamotrigine for epilepsy. Southern Med J 2000; 93: 335-336
  • 61 Grabowska-Grzyb A, Nagańska E, Wolańczyk T. Hypersexuality in two patients with epilepsy treated with lamotrigine. Epilepsy Behav 2006; 8: 663-665
  • 62 Calabrò RS, Bramanti P. Pregabalin-induced severe delayed ejaculation. Epilepsy Behav 2010; 19: 543
  • 63 Hitiris N, Barrett JA, Brodie MJ. Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: five case reports. Epilepsy Behav 2006; 8: 418-421
  • 64 Anderson GD. Pharmacogenetics and enzyme induction/inhibition properties of antiepiletics drugs. Neurology 2004; 63: S3-S8
  • 65 Andreasen AH, Brøsen K, Damkier P. A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on CYP3a4. Epilepsia 2007; 48: 490-496
  • 66 Basson R, Rees P, Wang R et al. Sexual function in chronic illness. J Sex Med 2010; 7: 374-388
  • 67 Shorvon SD. Hanbook of epilepsy. 3rd Edition 2010. Blackwell Publishing Ltd;
  • 68 Spina E, Perucca E. Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsia 2002; 43: 37-44
  • 69 Verrotti A, D’Egidio C, Mohn A et al. Antiepileptic drugs, sex hormones, and PCOS. Epilepsia 2011; 52: 199-211
  • 70 Devinsky O. Neurologist-induced sexual dysfunction: Enzyme-inducing antiepileptic drugs. Neurology 2005; 65: 980-981
  • 71 De Vries L, Karasik A, Landau Z et al. Endocrine effects of valproate in adolescent girls with epilepsy. Epilepsia 2007; 48: 470-477
  • 72 Blay SL, Ferraz MP, Calil HM. Lithium-induced male sexual impairment: two cases reports. J Clin Psychiatry 1982; 43: 497-498
  • 73 Kristensen E, Jørgensen P. Sexual function in lithium-treated manic-depressive patients. Pharmacopsychiatry 1987; 20: 165-167
  • 74 Ghadirian AM, Annable L, Bélanger MC. Lithium, benzodiazepines, and sexual function in bipolar patients. Am J Psychiatry 1992; 149: 801-805
  • 75 Aizenberg D, Sigler M, Zemishlany Z et al. Lithium and male sexual function in affective patients. Clin Neuropharmacol 1996; 19: 515-519
  • 76 Zuncheddu C, Carpiniello B. Sexual dysfunctions and bipolar disorder: a study of patients submitted to a long-term lithium treatment. La Clinica Terapeutica 2006; 157: 419-424
  • 77 Fossey MD, Hamner MB. Clonazepam-related sexual dysfunction in male veterans with PTSD. Anxiety 1994; 1: 233-236
  • 78 Lydiard RB, Howell EF, Laraia MT et al. Sexual side effects of alprazolam. Am J Psychiatry 1987; 144: 254-255
  • 79 Nutt D, Hackman A, Hawton K. Increased sexual function in benzodiazepine withdrawal. Lancet 1986; 2: 1101-1102
  • 80 Riley AJ, Riley EJ. The effect of sing le dose diazepam on female sexual response induced by masturbation. Sex Marital Ther 1986; 1: 49-53
  • 81 Sangal R. Inhibited female orgasm as a side effect of alprazolam. Am J Psychiatry 1985; 142: 1223-1224
  • 82 Segraves RT. Treatment of premature ejaculation with lorazepam. Am J Psychiatry 1987; 144: 1240
  • 83 Uhde TW, Tancer ME, Shea CA. Sexual dysfunction related to alprazolam treatment of social phobia. Am J Psychiatry 1988; 145: 531-532
  • 84 Balon R, Ramesh C, Pohl R. Sexual dysfunction associated with diazepam but not with clonazepam. Can J Psychiatry 1989; 34: 947-948
  • 85 Simões S, Amorim J, Machado A. Intense lorazepam-induced sexual arousal. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 236-237
  • 86 Fava M, Borofsky GF. Sexual disinhibition during treatment with a benzodiazepine: a case report. Int J Psychiatry Med 1991; 21: 99-104
  • 87 Kubacki A. Sexual disinhibition on clonazepam. Can J Psychiatry 1987; 32: 643-645
  • 88 Márquez M, Arenoso H, Caruso N. Efficacy of alprazolam sublingual tablets in the treatment of the acute phase of panic disorders. Actas Esp Psiquiatr 2011; 39: 88-94
  • 89 Orazzo C, Bortolotti F, Monteleone P. Gli psicofarmaci e la funzionalità sessuale nella pratica clinica. Available on line at http://www.psychiatryonline.it/node/2164 (accessed: 2 June 2013)
  • 90 Landén M, Eriksson E, Agren H et al. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999; 19: 268-271
  • 91 Norden MJ. Buspirone treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Depression 1994; 2: 109-112
  • 92 Othmer E, Othmer SC. Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder. J Clin Psychiatry 1987; 48: 201-203
  • 93 Stimmel GL, Gutierrez MA. Pharmacologic treatment strategies for sexual dysfunction in patients with epilepsy and depression. CNS Spectr 2006; 8: 31-37
  • 94 McGahuey CA, Gelenberg AJ, Laukes CA et al. The Arizona sexual experience scale (ASEX): reliability and validity. J Sex Marital Ther 2000; 26: 25-40
  • 95 Rosen R, Brown C, Heiman J et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 191-208
  • 96 Rosen RC, Riley A, Wagner G et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830
  • 97 Clayton AH, McGarvey EL, Clavet GJ. The changes in sexual functioning questionnaire (CSFQ): development, reliability and validity. Psycho­pharmacol Bull 1997; 33: 731-745
  • 98 Calabrò RS. Sexual disorders related to new antiepileptic drugs: a need for more studies!. Epilepsy Behav 2011; 20: 734-735
  • 99 Metin SZ, Ozmen M, Ozkara C et al. Hypersexuality in a patient with epilepsy during treatment of levetiracetam. Seizure 2013; 22: 151-152
  • 100 Calabrò RS, Bramanti P. Levetiracetam-induced sexual disorders. Seizure 2013; 22: 329
  • 101 Calabrò RS. Topiramate and sexual dysfunction: Myth or reality?. Epilepsy Behav 2013; 27: 424